In this free webinar, learn how precision medicine programs can be optimized through strategic lab partnerships, actionable data and multidisciplinary collaboration. Attendees will learn about the nuances of biomarkers as they enter the market. The featured speaker will share insights into opportunities and cost-effective interventions to remove barriers to patient identification. Attendees will learn about the critical role of labs in the precision medicine process. The speaker will discuss the underestimated value of labs in the precision medicine testing pathway.
TORONTO, Nov. 21, 2024 /PRNewswire-PRWeb/ -- As precision medicine continues to provide unique opportunities for patients, the management of the growing volume of information presents significant challenges for pharmaceutical companies when implementing effective programs.
The identification of biomarkers and engaging labs in the precision medicine journey is important. In this webinar, the expert speaker will demonstrate the effectiveness of impactful scientific engagement in enhancing the clinical utility of precision medicine.
With the expanding landscape of precision medicine, interpreting biomarker results is becoming increasingly pivotal. The key question now is: How can treating physicians be assisted in recognizing the clinical utility of this process?
By leveraging unique data sets, an extensive precision medicine network and experts from Diaceutics, pharmaceutical companies and treating physicians can get assistance in actioning therapeutics for appropriate patients. In this webinar, the attendees will gain insights into:
- How the nuances of biomarkers can be understood and managed
- How accurate prediction of opportunities and implementation of the most cost-effective interventions can remove barriers to maximize patient identification
- How labs are key stakeholders in the precision medicine process
- How labs and the local experts can be utilized to amplify precision medicine messaging
- How multidisciplinary involvement is more important than ever
- How well-informed and motivated lab partners are key to the success of any precision medicine asset
A multitude of stakeholders are involved in the precision medicine testing pathways, with the value of labs commonly being underestimated. It is a complicated process of scientific exchange combined with operational challenges and quality concerns.
Learn how the integration of proprietary data, broad Lab Network and unparalleled expertise in personal scientific lab engagement aid in devising strategies that activate optimal testing in the lab, the multidisciplinary team and even incorporate direct clinician engagement at pivotal moments—such as when biomarker-positive patients are identified—ensuring they receive the appropriate therapeutic options.
Register for this webinar today to discover how precision medicine programs can be optimized through strategic lab partnerships, actionable data and multidisciplinary collaboration.
Join Ken Ruppel, Vice President of Scientific and Medical Services, , for the on Thursday, December 12, 2024, at 1pm EST (10am PST).
For more information, or to register for this event, visit .
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit
For information about hosting a webinar visit
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected],
SOURCE Xtalks; Xtalks
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN62712&Transmission_Id=202411210830PR_NEWS_USPR_____UN62712&DateId=20241121)
Share this article